Sector valuations Genmab A/S Nasdaq

Stocks

GMAB

US3723032062

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 12/06/2026 BST 5-day change 1st Jan Change
25.08 USD -0.63% Intraday chart for Genmab A/S -0.28% -18.57%
Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
33.17x6.31x0.78x8.64x26.13x26.88x0.05% 56.42B
16.69x3.18x-1.74x5.03x10.91x12.67x1.8% 44.54B
-17.8x1.11x2.73x4.17x-7.3x-5.91x-.--% 22.9B
-36.36x49.71x0.63x12.23x-35.67x-38.43x-.--% 21.21B
20.25x1.99x1.42x3.95x10.26x12.34x-.--% 16.4B
16.8x4.76x1.22x4.85x11.36x12.45x-.--% 13.35B
-433.48x17.79x8.8x29.5x-3289.39x-322.93x-.--% 12.36B
36.9x9.16x0.41x14.16x41.61x37.07x0.18% 11.15B
-69.99x24.66x1.5x7.06x-63.29x-51.48x-.--% 11.08B
-23.6x24.23x-0x21.43x-27.5x-22.25x-.--% 10.5B
1704.21x7.77x-16.42x13.12x70.69x194.94x-.--% 10.82B
-12.33x144.96x0.6x3199.87x-14.94x-12.17x-.--% 10.87B
-21.49x8.24x10.94x796.88x-18.67x-18.58x-.--% 9.74B
-10.85x-44.97x9.35x81.82x-12.21x-11.88x-.--% 9.52B
-8.35x - -0.07x - - - - 7.44B
11x5.27x0.03x7.22x11.69x12.35x-.--% 7.93B
26.91x4.4x-2.15x6.07x23.62x26.95x - 7.33B
115.05x2.32x-2.02x4.62x22.91x50x0.13% 7.13B
Average 74.82x 15.93x 0.89x 248.27x -190.58x -5.76x 0.14% 16.15B
Weighted average by Cap. 51.78x 13.86x 0.71x 161.10x -137.97x -1.93x 0.31%
Bio Therapeutic Drugs
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!